JP Morgan increased its holdings in Ping An Healthcare and Technology Company Limited (01833) by approximately 1.34 million shares at a price of about 6.21 Hong Kong dollars per share.
On December 31st, Morgan Stanley increased its holdings in Ping An Healthcare (01833) by 1,340,431 shares, with an average price per share of 6.2090 Hong Kong dollars, totaling approximately 8.3227 million Hong Kong dollars.
The latest information from the Hong Kong Stock Exchange shows that on December 31, JP Morgan increased its holdings of Ping An Healthcare (01833) by 1,340,431 shares, with an average price per share of HKD 6.2090, for a total amount of approximately HKD 8.3227 million. After the increase, the latest number of shares held is approximately 67.3564 million, with a shareholding ratio of 6.02%.
Related Articles

Shanghai Kehua Bio-engineering (002022.SZ) has obtained a medical device registration certificate.

TIANBAO ENERGY (01671) has been awarded the highest AAA credit rating in the Tianjin electricity sales industry.

Zhejiang XCC Group (603667.SH) has applied to issue stocks to specific targets and has received approval from the China Securities Regulatory Commission.
Shanghai Kehua Bio-engineering (002022.SZ) has obtained a medical device registration certificate.

TIANBAO ENERGY (01671) has been awarded the highest AAA credit rating in the Tianjin electricity sales industry.

Zhejiang XCC Group (603667.SH) has applied to issue stocks to specific targets and has received approval from the China Securities Regulatory Commission.

RECOMMEND

Hong Kong Listed Companies’ Return To A Shares Heats Up As New “H To Shenzhen A” Case Emerges
05/01/2026

What Do The Top Ten Biopharma IPOs Of 2025 Tell Us?
05/01/2026

Asia’s Stock Markets Deliver A Strong 2025: Korea Soars 76%, Japan Tops Bubble‑Era Peak, Indonesia Records Best Year In 11 Years
05/01/2026


